Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Enumeral Biomedical Holdings, Inc. (ENUM)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Enumeral Biomedical Holdings, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Enumeral Biomedical Holdings, Inc. since 2005.
The reporting company's ticker symbol is ENUM. The reporting company's CIK number is 1561551.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $174,500.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2016-12-09||Fayad Wael (Chairman, President, CEO)||Option Ex||298,000||.12||37,250|
|2016-12-09||Buckland Barry||Option Ex||52,000||.12||6,500|
|2016-12-09||Sarney Kevin G (VP, Finance and CAO)||Option Ex||35,000||.12||4,375|
|2016-12-09||Sekhri Paul J||Option Ex||175,000||.12||21,875|
|2016-12-09||Van Nostrand Robert L||Option Ex||156,000||.12||19,500|
|2016-12-09||Easton Robert J||Option Ex||480,000||.12||60,000|
|2016-12-09||Rothstein Allan P||Option Ex||200,000||.12||25,000|
Insider trading activities including stock purchases, stock sales, and option exercises of ENUM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Enumeral Biomedical Holdings, Inc. (symbol ENUM, CIK number 1561551) see the Securities and Exchange Commission (SEC) website.